This is not the most recent version of the article. View current version (3 MAY 2014)

Intervention Protocol

Aminoadamantanes for chronic hepatitis C

  1. Mieke H Lamers1,2,*,
  2. Mark Broekman1,
  3. Joost Drenth1,
  4. Christian Gluud2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 26 JUL 2012

DOI: 10.1002/14651858.CD010125


How to Cite

Lamers MH, Broekman M, Drenth J, Gluud C. Aminoadamantanes for chronic hepatitis C (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010125. DOI: 10.1002/14651858.CD010125.

Author Information

  1. 1

    Radboud University Medical Center Nijmegen, Department of Gastroenterology and Hepatology, Nijmegen, Netherlands

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Mieke H Lamers, m.lamers@mdl.umcn.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

This is not the most recent version of the article. View current version (03 MAY 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To explore the beneficial and harmful effects of aminoadamantanes for patients with chronic HCV infection in a systematic review with meta-analysis and with trial sequential analysis of randomised clinical trials.